In line with previous report (9), our current results suggested a decreased serum IL-9 and circulating non-specific and HBV-specific Th9 cells, but not Tc9 cells, in CHB and hepatitis B-related HCC. The gene discussed is IL9; the disease is hepatocellular carcinoma.